Dapagliflozin Tablet, Film Coated
Product Images NDC 50090-7971

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dapagliflozin (NDC 50090-7971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Scatter Plot And Fitted Line Of Change From Baseline In 24-hour Urinary Glucose Amount Versus Dapagliflozin Dose In Healthy Subjects And Subjects With Type 2 Diabetes Mellitus (t2dm) (semi-log Plot) (Dapagliflozin Fig1)

Figure 1: Scatter Plot And Fitted Line Of Change From Baseline In 24-hour Urinary Glucose Amount Versus Dapagliflozin Dose In Healthy Subjects And Subjects With Type 2 Diabetes Mellitus (t2dm) (semi-log Plot) (Dapagliflozin Fig1)
FDA Label Image

Figure 2: Adjusted Mean Change From Baseline Over Time In Hba1c (%) In A 24-week Active-controlled Study Of Dapagliflozin Initial Combination Therapy With Metformin Xr (Dapagliflozin Fig2)

Figure 2: Adjusted Mean Change From Baseline Over Time In Hba1c (%) In A 24-week Active-controlled Study Of Dapagliflozin Initial Combination Therapy With Metformin Xr (Dapagliflozin Fig2)
The text provides information about the adjusted mean change from baseline in a study comparing the effects of Dapagliflozin 10 mg + Metformin, Dapagliflozin 10 mg alone, and Metformin alone on HbA1c levels over a 24-week period. The study includes graphs displaying the adjusted mean change from baseline values based on a longitudinal repeated measures model and an ANCOVA model. The left side graph includes values for subjects who completed the study without rescue, while the right side graph includes values for subjects with at least one post-baseline HbA1c measurement before rescue at Week 24.*
FDA Label Image

Figure 3 (Dapagliflozin Fig3)

Figure 3 (Dapagliflozin Fig3)
FDA Label Image

Figure (Dapagliflozin Fig4)

Figure (Dapagliflozin Fig4)
FDA Label Image

Figure (Dapagliflozin Fig5)

Figure (Dapagliflozin Fig5)
FDA Label Image

Chemical Structure (Dapagliflozin Str)

Chemical Structure (Dapagliflozin Str)
FDA Label Image

Label Image (Lbl500907971)

Label Image (Lbl500907971)
This is a description of a product labeled as Dapagliflozin, with a strength of 5 mg, and containing 30 tablets. The product number provided is 7214-0. The location or storage recommendation is to store it at 8-10°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.